ABSTRACT The new generation of nanotechnology-based drug formulations is challenging the accepted ways of cancer treatment. Multi-functional nanomaterial constructs have the capability to be delivered directly to the tumor site and eradicate cancer cells selectively, while sparing healthy cells. Tailoring of the nano-construct design can result in enhanced drug efficacy at lower doses as compared to free drug treatment, wider therapeutic window, and lower side effects. Nanoparticle carriers can also address several drug delivery problems which could not be effectively solved in the past and include reduction of multi-drug resistance effects, delivery of siRNA, and penetration of the blood-brain-barrier. Although challenges in understanding toxicity, biodistribution, and paving an effective regulatory path must be met, nanoscale devices carry a formidable promise to change ways cancer is diagnosed and treated. This article summarizes current developments in nanotechnology-based drug delivery and discusses path forward in this field. The discussion is done in context of research and development occurring within the NCI Alliance for Nanotechnology in Cancer program.
NCI                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/National_Cancer_Institute

blood-brain-barrier           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bloodâ€“brain_barrier   

drug delivery                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Drug_delivery         

Nanotechnology                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanotechnology        

biodistribution               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Biodistribution       

nanomaterial                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanomaterials         

siRNA                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Small_interfering_RNA 

cancer                        0.99999996594886^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Cancer                

nanoscale                     0.990783433610405^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Nanotechnology        

therapeutic window            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Therapeutic_window    

tumor                         0.9994804088039599^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Tumor                 

cells                         0.9999999999998863^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cell_(biology)        

cancer                        0.99999996594886^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Cancer                

drug delivery                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Drug_delivery         

cells                         0.9999999999998863^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cell_(biology)        

cancer                        0.99999996594886^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Cancer                

multi-drug resistance         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Multiple_drug_resistance

